Incidence and aetiology of eosinophilic pleural effusion

European Respiratory Journal

Volumn 34, Issue 5, 2009, Pages 1111-1117

  Krenke, R ^a   Nasilowski, J ^a   Korczynski, P ^a   Gorska, K ^a   Przybylowski, T ^a   Chazan, R ^a   Light, R W ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Eosinophilic pleural effusion; Eosinophils; Pleural effusion; Pleural fluid; Pleural fluid eosinophilia

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; EOSINOPHILIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PLEURA EFFUSION; PLEURA FLUID; PLEURISY; PRIORITY JOURNAL; THORACOCENTESIS;

ADULT; AGED; AGED, 80 AND OVER; AUTOMATION; EOSINOPHILIA; EOSINOPHILS; ERYTHROCYTES; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; PLEURAL EFFUSION; PULMONARY MEDICINE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 71049131675     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00197708     Document Type: Article

References (34)

1. Adelman M, Albelda SM, Gottlieb J, et al. Diagnostic utility of pleural fluid eosinophilia. Am J Med 1984; 77: 915-920. (Pubitemid 15204874)
2. Kalomenidis I, Light RW. Eosinophilic pleural effusions. Curr Opin Pulm Med 2003; 9: 254-260.
3. Kuhn M, Fitting JW, Leuenberger P. Probability of malignancy in pleural fluid eosinophilia. Chest 1989; 9: 992-994. (Pubitemid 19266545)
4. Martinez-Garcia MA, Cases-Viedma E, Cordero-Rodriguez PJ, et al. Diagnostic utility of eosinophils in the pleural fluid. Eur Respir J 2000; 15: 166-169. (Pubitemid 30068955)
5. Rubins JB, Rubins HB. Etiology and prognostic significance of eosinophilic pleural effusions. A prospective study. Chest 1996; 110: 1271-1274.
6. Oda M, Satouchi K, Ikeda I, et al. The presence of platelet-activating factor associated with eosinophil and/or neutrophil accumulation in pleural fluids. Am Rev Respir Dis 1990; 141: 1469-1473. (Pubitemid 20201344)
7. Wysenbeek AJ, Lahav M, Aelion JA, et al. Eosinophilic pleural effusion: a review of 36 cases. Respiration 1985; 48: 73-76. (Pubitemid 15056599)
8. Light RW. Pleural diseases. 5th Edn. Wolters-Kluwer/Lippincott Williams & Wilkins, Philadelphia, 2007.
9. Light RW, MacGregor MI, Luchsinger PC, et al. Pleural effusions: the diagnostic separations of transudates and exudates. Ann Intern Med 1972; 77: 507-513.
10. Porcel JM, Vives M, Vicente de Vera MC, et al. Useful tests on pleural fluid that distinguish transudates from exudates. Ann Clin Biochem 2001; 38: 671-675. (Pubitemid 33702273)
11. Romero-Candeira S, Hernández L. The separation of transudates and exudates with particular reference to the protein gradient. Curr Opin Pulm Med 2004; 10: 294-298. (Pubitemid 38803123)
12. Kinasewitz GT. Transudative effusions. Eur Respir J 1997; 10: 714-718.
13. Light RW. Diagnostic principles in pleural disease. Eur Respir J 1997; 10: 476-481.
14. Valdés L, Pose A, San José E, et al. Tuberculous pleural effusion. Eur J Intern Med 2003; 14: 77-88.
15. Hamm H, Light RW. Parapneumonic effusion and empyema. Eur Respir J 1997; 10: 1150-1156.
16. Kamel A, Chabbou A, El Gharbi B. [Apport diagnostique de l'eosinophilie pleurale.]. Rev Pneumol Clin 1989; 45: 118-122.
17. Marel M. Epidemiology of pleural effusion. In: Loddenkemper R, Antony VB, eds. Pleural Diseases. Eur Respir Mon 2002; 22: 146-156.
18. Ferrer JS, Muñoz XG, Orriols RM, et al. Evolution of idiopathic pleural effusion: a prospective, long-term follow-up study. Chest 1996; 109: 1508-1513. (Pubitemid 26193376)
19. Schandené L, Namias B, Crusiaux A, et al. IL-5 in post-traumatic eosinophilic pleural effusion. Clin Exp Immunol 1993; 93: 115-119. (Pubitemid 23195949)
20. de Blay F, Aykut-Baturalp A, Goetz J, et al. Post-traumatic pleural effusion: demonstration of local complement consumption. Respir Med. 1997; 91: 373-375. (Pubitemid 27270353)
21. Light RW. Pleural effusions after coronary artery bypass graft surgery. Curr Opin Pulm Med 2002; 8: 308-311. (Pubitemid 34625965)
22. Mohamed KH, Abdelhamid AI, Lee YC, et al. Pleural fluid levels of interleukin-5 and eosinophils are closely correlated. Chest 2002; 122: 576-580.
23. Nakamura Y, Ozaki T, Kamei T, et al. Factors that stimulate the proliferation and survival of eosinophils in eosinophilic pleural effusion: relationship to granulocyte/macrophage colony-stimulating factor, interleukin-5, and interleukin-3. Am J Respir Cell Mol Biol 1993; 8: 605-611.
24. Kalomenidis I, Mohamed KH, Lane KB, et al. Pleural fluid levels of vascular cell adhesion molecule-1 are elevated in eosinophilic pleural effusions. Chest 2003; 124: 159-166. (Pubitemid 36851348)
25. Kalomenidis I, Light RW. Pathogenesis of the eosinophilic pleural effusions. Curr Opin Pulm Med 2004; 10: 289-293.
26. Light RW, Rogers JT, Moyers JP, et al. Prevalence and clinical course of pleural effusions at 30 days after coronary artery and cardiac surgery. Am J Respir Crit Care Med 2002; 166: 1567-1571.
27. Sadikot RT, Rogers JT, Cheng DS, et al. Pleural fluid characteristics of patients with symptomatic pleural effusion after coronary artery bypass graft surgery. Arch Intern Med 2002; 160: 2665-2668.
28. Kalomenidis I, Guo Y, Peebles RS, et al. Pneumothorax-associated pleural eosinophilia in mice is interleukin-5 but not interleukin-13 dependent. Chest 2005; 128: 2978-2983. (Pubitemid 41507657)
29. Kalomenidis I, Moschos C, Kollintza A, et al. Pneumothorax-associated pleural eosinophilia is tumour necrosis factor-α-dependent and attenuated by steroids. Respirology 2008; 13: 73-78.
30. Smit HJ, van den Heuvel MM, Barbierato SB, et al. Analysis of pleural fluid in idiopathic spontaneous pneumothorax; correlation of eosinophil percentage with the duration of air in the pleural space. Respir Med 1999; 93: 262-267.
31. De Smedt A, Vanderlinden E, Demanet C, et al. Characterisation of pleural inflammation occurring after primary spontaneous pneumothorax. Eur Respir J 2004; 23: 896-900. (Pubitemid 38807365)
32. Chung CL, Chen YC, Chang SC. Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion. Chest 2003; 123: 1188-1195.
33. Chung CL, Yeh CY, Sheu JR, et al. Repeated thoracenteses affect proinflammatory cytokines, vascular endothelial growth factor, and fibrinolytic activity in pleural transudates. Am J Med Sci 2007; 334: 452-457.
34. Martinez-Garcia MA, Cases Viedma E, Perpiñá Tordera M, et al. Repeated thoracentesis: an important risk factor for eosinophilic pleural effusion? Respiration 2003; 70: 82-86.